Pyrroloquinoline quinone influences intracellular alpha-synuclein aggregates
Parkinson’s disease (PD) is an irreversible neurodegenerative disorder clinically manifesting in uncontrolled motor symptoms. There are two primary hallmark features of Parkinson’s disease—an irreversible loss of dopaminergic neurons of the substantia nigra pars compacta and formation of intracellul...
Main Authors: | Elizabeth Mountford, Cynthia Mathew, Reena Ghildyal, Andrea Bugarcic, Vitor Francisco |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-01-01
|
Series: | Experimental Results |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2516712X23000102/type/journal_article |
Similar Items
-
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
by: Rachel Kelly, et al.
Published: (2021-11-01) -
Transcriptome analysis of the effect of pyrroloquinoline quinone disodium (PQQ·Na2) on reproductive performance in sows during gestation and lactation
by: Boru Zhang, et al.
Published: (2019-08-01) -
Pyrroloquinoline-quinone to reduce fat accumulation and ameliorate obesity progression
by: Nur Syafiqah Mohamad Ishak, et al.
Published: (2023-05-01) -
Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
by: Janett Köppen, et al.
Published: (2020-01-01) -
Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy
by: Qi Zhang, et al.
Published: (2020-09-01)